Evotec Competitors and Similar CompaniesClear all
Evotec's competitors and similar companies include Eurofins and Catalent.
 Catalent Catalent is a company that develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, vaccines, and consumer health products. | |||
Founding Date | Founding Date 1993 | Founding Date 1987 | Founding Date 2007 |
Type | Type Public | Type Public | Type Subsidiary |
Tags | |||
Locations | Locations Hamburg, DE HQ Lyon, FR Toulouse, FR Göttingen, DE Halle (Westfalen), DE Köln, DE Munich, DE see more | Locations Bridgewater, US HQ Buenos Aires, AR Bruxelles, BE Charleroi, BE Charleroi, BE Charleroi, BE Indaiatuba, BR see more | |
Employees | Employees 4,766 | Employees 65,0004% increase | Employees 12,6955% increase |
Valuation ($) | Valuation ($) 1.4 b | Valuation ($) 9.5 b | Valuation ($) N/A |
Financial | |||
Revenue (est.) | Revenue (est.) €788.4m (FY, 2025) | Revenue (est.) €7.3b (FY, 2025) | Revenue (est.) $4.4b (FY, 2024) |
Cost of goods | Cost of goods €622.9m (FY, 2025) | Cost of goods €2.3b (FY, 2025) | Cost of goods $3.4b (FY, 2024) |
Gross profit | Gross profit €231.1m (FY, 2025) | Gross profit €5b (FY, 2025) | Gross profit $953m (FY, 2024) |
Net income | Net income (€103.5m) (FY, 2025) | Net income €473m (FY, 2025) | Net income ($1b) (FY, 2024) |
Operating ⚠ | |||
Countries | Countries N/A | Countries 62 (FY, 2023) | Countries 80 (FY, 2023) |
Customers | Customers 781 (FY, 2023) | Customers N/A | Customers 1.2 k (FY, 2023) |
Products | Products 140 (FY, 2023) | Products N/A | Products 8 k (FY, 2023) |
Funding | |||
Total funding raised | Total funding raised $ 993.6m | Total funding raised $ 30m | Total funding raised $ 650m |
For sources of this data, please see the company profile
View Company Profiles
Eurofins
HQ
Luxembourg, LU
Employees
65,000↑ 4% increase
Eurofins Scientific is a life sciences company providing laboratory services.
View companyCatalent
HQ
Bridgewater, US
Catalent is a company that develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, vaccines, and consumer health products.
View company